Furthermore, exosomes derived from mesenchymal stem cells (MSCs) inhibit macrophage inflammation by activating the SIRT1-FXR signaling pathway and reduce NLRP3 inflammasome activation, thereby alleviating IBD inflammation [477, 478]. Here, NR1H4 is linked to inflammatory bowel disease.